# No Correlation Between Interferon Signaling and Cytosolic Mitochondrial DNA/RNA Leakage in Cultured Skin Fibroblasts of Patients With Mitochondrial Diseases

**Authors:** Manon Marchais, Alessandra Pennisi, Alexandre Pierga, Alice Lepelley, Nicolas Cagnard, Christine Bole, Patrick Nitschke, Mohamed Hamici, Frédéric Rieux‐Laucat, Manuel Schiff, Arnold Munnich, Agnès Rötig

PMC · DOI: 10.1002/eji.70176 · European Journal of Immunology · 2026-03-27

## TL;DR

This study shows that cultured skin fibroblasts from mitochondrial disease patients are useful for studying interferon signaling, but abnormal signaling and mitochondrial DNA/RNA leakage are not consistently linked.

## Contribution

The study reveals inconsistent interferon signaling and weak correlation with mitochondrial DNA/RNA leakage in mitochondrial disease patient fibroblasts.

## Key findings

- Only 43% of patients’ fibroblasts showed increased interferon-stimulated gene scores.
- No correlation was found between elevated interferon response and cytosolic mitochondrial DNA/RNA leakage.
- Cytosolic mtDNA and mtRNA accumulation varied and showed little correlation with interferon signaling scores.

## Abstract

Mitochondria have long been known to be involved in the regulation of innate immune response. We questioned whether cultured skin fibroblasts of patients suffering from mitochondrial diseases are valuable biological resources for the study of interferon signaling. Expression of interferon‐stimulated genes was measured in control cells supplemented with interferon and in cultured fibroblasts of patients carrying pathogenic variants in mitochondrial disease‐causing genes. Control fibroblasts showed a strong expression of interferon‐stimulated genes in response to interferon, but only 43% of patients’ fibroblasts displayed increased interferon stimulated genes scores. Cytosolic mitochondrial DNA and RNA were quantified by immunofluorescence and confocal microscopy. No correlation between elevated interferon response and cytosolic mitochondrial DNA or RNA release could be established. We found that cultured skin fibroblasts represent a valuable biological resource for the investigation of interferon signaling, but that abnormal interferon signaling is not always observed in patients with mitochondrial diseases. At variance to gene silencing in control fibroblasts, the lack of correlation between elevated interferon response and cytosolic mitochondrial DNA or RNA leakage in patients’ fibroblasts questions the relevance of cellular models as illustrators of pathological situations in humans.

Investigation of IFN signaling in cultured skin fibroblasts from patients with genetically confirmed mitochondrial diseases of diverse origins revealed that altered IFN signaling is an inconsistent feature of these disorders. Cytosolic accumulation of mtDNA and mtRNA was variably detected and showed little correlation with ISG scores.

## Full-text entities

- **Genes:** TMEM132E (transmembrane protein 132E) [NCBI Gene 124842] {aka DFNB99}, RNU7-1 (RNA, U7 small nuclear 1) [NCBI Gene 100147744] {aka AGS9, RNU7, U7.1}, ATAD3A (ATPase family AAA domain containing 3A) [NCBI Gene 55210] {aka HAYOS, PHRINL}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, TYMP (thymidine phosphorylase) [NCBI Gene 1890] {aka ECGF, ECGF1, MEDPS1, MNGIE, MTDPS1, PDECGF}, ISG15 (ISG15 ubiquitin like modifier) [NCBI Gene 9636] {aka G1P2, IFI15, IMD38, IP17, UCRP, hUCRP}, TRMT10C (tRNA methyltransferase 10C, mitochondrial RNase P subunit) [NCBI Gene 54931] {aka COXPD30, HNYA, MRPP1, RG9MTD1}, POLG2 (DNA polymerase gamma 2, accessory subunit) [NCBI Gene 11232] {aka HP55, MTDPS16, MTDPS16A, MTDPS16B, MTPOLB, PEOA4}, IRF2 (interferon regulatory factor 2) [NCBI Gene 3660] {aka IRF-2}, REXO2 (RNA exonuclease 2) [NCBI Gene 25996] {aka CGI-114, REX2, RFN, SFN}, IFI16 (interferon gamma inducible protein 16) [NCBI Gene 3428] {aka IFNGIP1, PYHIN2}, IFI27 (interferon alpha inducible protein 27) [NCBI Gene 3429] {aka FAM14D, ISG12, ISG12A, P27}, DGUOK (deoxyguanosine kinase) [NCBI Gene 1716] {aka MTDPS3, NCPH, NCPH1, PEOB4, dGK}, POLG (DNA polymerase gamma, catalytic subunit) [NCBI Gene 5428] {aka MIRAS, MTDPS4A, MTDPS4B, PEO, POLG1, POLGA}, IFI44L (interferon induced protein 44 like) [NCBI Gene 10964] {aka C1orf29, GS3686, TLDC5B}, TOMM40 (translocase of outer mitochondrial membrane 40) [NCBI Gene 10452] {aka C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40}, MRPL12 (mitochondrial ribosomal protein L12) [NCBI Gene 6182] {aka 5c5-2, L12mt, MRP-L31/34, MRPL7, MRPL7/L12, RPML12}, TBK1 (TANK binding kinase 1) [NCBI Gene 29110] {aka AIARV, FTDALS4, IIAE8, NAK, T2K}, TAF5LP1 (TATA-box binding protein associated factor 5 like pseudogene 1) [NCBI Gene 645744] {aka HsT33855, TAF5LP}, TRMU (tRNA mitochondrial 2-thiouridylase) [NCBI Gene 55687] {aka LCAL3, MTO2, MTU1, TRMT}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, RSAD2 (radical S-adenosyl methionine domain containing 2) [NCBI Gene 91543] {aka SAND, cig33, cig5, vig1}, FH (fumarate hydratase) [NCBI Gene 2271] {aka FMRD, HLRCC, HsFH, LRCC, MCL, MCUL1}, LINC01629 (long intergenic non-protein coding RNA 1629) [NCBI Gene 105370578] {aka linc-KIAA1737-2}, IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, IRF1 (interferon regulatory factor 1) [NCBI Gene 3659] {aka IMD117, IRF-1, MAR}, NDUFAF6 (NADH:ubiquinone oxidoreductase complex assembly factor 6) [NCBI Gene 137682] {aka C8orf38, FRTS5, MC1DN17, lncREST}, TFAM (transcription factor A, mitochondrial) [NCBI Gene 7019] {aka MTDPS15, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2}, IFIT1 (interferon induced protein with tetratricopeptide repeats 1) [NCBI Gene 3434] {aka C56, G10P1, IFI-56, IFI-56K, IFI56, IFIT-1}, IFITM1 (interferon induced transmembrane protein 1) [NCBI Gene 8519] {aka 9-27, CD225, DSPA2a, IFI17, LEU13}, MTO1 (mitochondrial tRNA translation optimization 1) [NCBI Gene 25821] {aka CGI-02, COXPD10}, PNPT1 (polyribonucleotide nucleotidyltransferase 1) [NCBI Gene 87178] {aka COXPD13, DFNB70, OLD35, PNPASE, SCA25, old-35}, SDS (serine dehydratase) [NCBI Gene 10993] {aka SDH, hSDH}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, ELAC2 (elaC ribonuclease Z 2) [NCBI Gene 60528] {aka COXPD17, ELC2, HPC2}, IRF9 (interferon regulatory factor 9) [NCBI Gene 10379] {aka IRF-9, ISGF3, ISGF3G, p48}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, IRF2BPL (interferon regulatory factor 2 binding protein like) [NCBI Gene 64207] {aka C14orf4, EAP1, NEDAMSS}, IFIT5 (interferon induced protein with tetratricopeptide repeats 5) [NCBI Gene 24138] {aka ISG58, P58, RI58}, DCLK3 (doublecortin like kinase 3) [NCBI Gene 85443] {aka CLR, DCAMKL3, DCDC3C, DCK3}, HPRT1 (hypoxanthine phosphoribosyltransferase 1) [NCBI Gene 3251] {aka HGPRT, HPRT}, LSM11 (LSM11, U7 small nuclear RNA associated) [NCBI Gene 134353] {aka AGS8}, TRNT1 (tRNA nucleotidyl transferase 1) [NCBI Gene 51095] {aka CCA1, CGI-47, MtCCA, RPEM, SIFD}, MPV17 (mitochondrial inner membrane protein MPV17) [NCBI Gene 4358] {aka CMT2EE, MTDPS6, SYM1}, TRNF (tRNA-Phe) [NCBI Gene 4558], GTPBP3 (GTP binding protein 3, mitochondrial) [NCBI Gene 84705] {aka COXPD23, GTPBG3, MSS1, MTGP1, THDF1}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, RNASET2 (ribonuclease T2) [NCBI Gene 8635] {aka RNASE6PL, bA514O12.3}, TWNK (twinkle mtDNA helicase) [NCBI Gene 56652] {aka ATXN8, C10orf2, IOSCA, MTDPS7, PEO, PEO1}, NDUFA6 (NADH:ubiquinone oxidoreductase subunit A6) [NCBI Gene 4700] {aka B14, CI-B14, LYRM6, MC1DN33, NADHB14}, TOP3A (DNA topoisomerase III alpha) [NCBI Gene 7156] {aka MGRISCE2, PEOB5, TOP3, ZGRF7}
- **Diseases:** sideroblastic anemia (MESH:D000756), Friedreich ataxia (MESH:D005621), type I interferonopathies (MESH:D006969), leukoencephalopathy (MESH:D056784), immunodeficiency (MESH:D007153), Mitochondrial Diseases (MESH:D028361), CMV infection (MESH:D003586), systemic sclerosis (MESH:D012595), polyradiculoneuritis (MESH:D011129), immune abnormalities (MESH:D007154), neuroinflammation (MESH:D000090862), Progressive External Ophthalmoplegia (MESH:D017246), neurological, hepatic, and gastrointestinal symptoms (MESH:D012817), MELAS (MESH:D017241), lactic acidosis (MESH:D000140), cystic (MESH:D018297), fumarase deficiency (MESH:C538191), lupus (MESH:D008180), autoimmune disease (MESH:D001327), autoinflammatory diseases (MESH:D056660), mitochondrial defects (MESH:C565376), inflammation (MESH:D007249), mitochondrial encephalomyopathy (MESH:D017237), AGS (MESH:C535607)
- **Chemicals:** Triton X-100 (MESH:D017830), Alexa 594 (MESH:C417664), Alexa 488 (-), Alexa Fluor 488 (MESH:C000711379), Alexa 647 (MESH:C569686), DAPI (MESH:C007293), paraformaldehyde (MESH:C003043), TBS (MESH:D013725), PBS (MESH:D007854), water (MESH:D014867), itaconate (MESH:C005229), Tween (MESH:D011136)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Mycoplasma (genus) [taxon 2093]
- **Mutations:** c.458G>A, m.616T>C, c.31_32insG, c.2T>A, T>C, c.625_627del, c.408G>T, p.Thr457Ile, c.708-20A>G, Trp748Ser, p.Ala648Val, p.Pro587Leu, c.975dup, p.Val1043Glyfs, c.2420G>C, c.1399G>A, c.3125dup, c.208T>C, c.3286C>T, c.1577C>T, p.Lys561Met, c.1510C>T, c.542G>T, c.1682A>T, p.Arg232His, p.Asp713Tyr, p.Leu428Pro, c.1603G>T, c.1760C>T, c.1160A>G, c.2554C>T, c.3314C>T, c.1982G>A, c.407G>A, c.542C>T, c.2249T>C, c.695G>A, c.591G>A, p.Asp1184Asn, c.428C>T, p.Ala178Pro, c.2137G>T, c.251C>T, c.498C>A, p.Gly848Ser
- **Cell lines:** POLG-10 — Homo sapiens (Human), Alveolar rhabdomyosarcoma, Cancer cell line (CVCL_C1D0), MEF — Mus musculus (Mouse), Finite cell line (CVCL_9115), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13022800/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13022800/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC13022800/full.md

---
Source: https://tomesphere.com/paper/PMC13022800